Question

A 52-year-old man with long-standing alcohol use presents with jaundice and mild ascites. Laboratory tests show total bilirubin of 4.8 mg/dL, AST 48 U/L, ALT 45 U/L, and INR 1.8. Viral hepatitis serology is negative, and ultrasound shows a coarse echotexture liver with features of portal hypertension. What is the most appropriate method to determine the cause of cirrhosis in this patient?

• A. Liver elastography
• B. Transjugular biopsy
• C. Percutaneous biopsy
• D. FNAC liver

Hint:

Absolute contraindications to standard percutaneous liver biopsy include: severe coagulopathy (INR $> 1.5$), severe thrombocytopenia, massive ascites, and suspected highly vascular lesions like hemangiomas. Always choose the transjugular route for these patients.

Answer 1

The Correct Option is B

Concept:
A middle-aged man with a strong clinical history of chronic alcohol consumption presents with overt clinical signs of advanced decompensated cirrhosis, prominently including ascites and severe synthetic dysfunction manifested by a significantly elevated INR of 1.8.
While the clinical etiology is likely alcohol-related, a tissue biopsy is required for definitive diagnostic confirmation. The challenge is to select the safest procedural modality for obtaining this biopsy in a highly coagulopathic patient with ascites.
Explanation:
• A histological liver biopsy remains a critical diagnostic tool when determining the precise underlying etiology of cirrhosis, evaluating the exact degree of architectural fibrotic disruption, and ruling out complex overlapping pathologies.

• The standard, traditional approach to obtaining liver tissue is the percutaneous liver biopsy (Option C).

• However, a percutaneous biopsy involves inserting a needle directly through the abdominal wall and the highly vascular liver capsule. It is absolutely contraindicated in patients with severe bleeding diatheses (typically defined as an INR $> 1.5$ or platelets $< 50,000$) and in patients with moderate to massive ascites, due to an unacceptably high risk of massive, fatal intraperitoneal hemorrhage.

• In such complex patients, the transjugular liver biopsy (Option B) is the safest and most appropriate interventional method.

• This highly specialized procedure involves advancing a catheter down the internal jugular vein, through the right heart, and directly into the hepatic vein. The biopsy needle is then deployed outwards from within the hepatic vein into the liver parenchyma.

• Because the entire needle tract remains completely within the systemic venous system, any subsequent bleeding flows harmlessly back into the hepatic venous circulation rather than spilling out freely into the peritoneal cavity.

• Liver elastography (Option A), such as FibroScan, is an excellent non-invasive ultrasound technique used to simply quantify the "stiffness" or degree of fibrosis, but it absolutely cannot determine the underlying molecular or histological etiology of the disease.

• Fine Needle Aspiration Cytology (FNAC) of the liver (Option D) only extracts loose, disorganized clusters of cells; it completely destroys the underlying tissue architecture, making it entirely useless for diagnosing complex architectural diseases like cirrhosis.
Final Answer:
Due to the significant presence of coagulopathy (high INR) and ascites, a transjugular biopsy is the safest and most appropriate method to obtain liver tissue.